Her2 crosstalks with TrkA in a subset of prostate cancer cells: rationale for a guided dual treatment.

Festuccia, Claudio; Gravina, Giovanni Luca; Muzi, Paola; Millimaggi, Danilo; Dolo, Vincenza; Vicentini, Carlo; Ficorella, Corrado; Ricevuto, Enrico; Bologna, Mauro

Festuccia, Claudio; Gravina, Giovanni Luca; Muzi, Paola; Millimaggi, Danilo; Dolo, Vincenza; Vicentini, Carlo; Ficorella, Corrado; Ricevuto, Enrico; Bologna, Mauro.

Affiliation

Festuccia C; Department of Experimental Medicine, Chair of General Pathology, University of L'Aquila, Italy. festucci@univaq.it

Prostate ; 69(4): 337-45, 2009 Mar 01.

Article in En | MEDLINE | ID: mdl-19016477

Subject(s)

Antibodies, Monoclonal/therapeutic use; Carbazoles/therapeutic use; Prostatic Neoplasms/drug therapy; Prostatic Neoplasms/metabolism; Receptor Cross-Talk/physiology; Receptor, ErbB-2/metabolism; Receptor, trkA/metabolism; Animals; Antibodies, Monoclonal/pharmacology; Antibodies, Monoclonal, Humanized; Carbazoles/pharmacology; Cell Line, Tumor; Cell Proliferation/drug effects; Drug Therapy, Combination; Furans; Male; Mice; Nerve Growth Factor/pharmacology; Prostatic Neoplasms/pathology; Receptor Cross-Talk/drug effects; Receptor, ErbB-2/drug effects; Receptor, trkA/drug effects; Receptors, Androgen/drug effects; Xenograft Model Antitumor Assays

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Carbazoles / Receptor, ErbB-2 / Receptor Cross-Talk / Receptor, trkA / Antibodies, Monoclonal Type of study: Prognostic_studies Limits: Animals Language: En Journal: Prostate Year: 2009 Document type: Article Affiliation country: Italy Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google